Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression.

Publication ,  Other
Mosca, PJ; Robertson, GP
Published in: Cancer Biol Ther
March 15, 2011

Duke Scholars

Published In

Cancer Biol Ther

DOI

EISSN

1555-8576

Publication Date

March 15, 2011

Volume

11

Issue

6

Start / End Page

581 / 583

Location

United States

Related Subject Headings

  • T-Lymphocytes
  • Skin Neoplasms
  • Phagocytosis
  • Oncology & Carcinogenesis
  • Melanoma
  • Ipilimumab
  • Interleukin-2
  • Immunotherapy
  • Humans
  • Calreticulin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mosca, P. J., & Robertson, G. P. (2011). Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression. Cancer Biol Ther. United States. https://doi.org/10.4161/cbt.11.6.14697
Mosca, Paul J., and Gavin P. Robertson. “Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression.Cancer Biol Ther, March 15, 2011. https://doi.org/10.4161/cbt.11.6.14697.
Mosca, Paul J., and Gavin P. Robertson. “Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression.Cancer Biol Ther, vol. 11, no. 6, 15 Mar. 2011, pp. 581–83. Pubmed, doi:10.4161/cbt.11.6.14697.

Published In

Cancer Biol Ther

DOI

EISSN

1555-8576

Publication Date

March 15, 2011

Volume

11

Issue

6

Start / End Page

581 / 583

Location

United States

Related Subject Headings

  • T-Lymphocytes
  • Skin Neoplasms
  • Phagocytosis
  • Oncology & Carcinogenesis
  • Melanoma
  • Ipilimumab
  • Interleukin-2
  • Immunotherapy
  • Humans
  • Calreticulin